CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
- 29 July 2008
- journal article
- case report
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Oncology
- Vol. 5 (9), 557-561
- https://doi.org/10.1038/ncponc1183
Abstract
Background A 63-year-old female presented to her primary physician with numbness and weakness in her left leg, which progressed over several days to involve her entire lower extremities. MRI of the spine and brain revealed multiple metastases. The patient received ipilimumab and after 3 months experienced intermittent confusion and focal seizures. Investigations Electroencephalogram and MRI scans of the spine and brain, followed by surgical removal of a left frontal cortical brain metastasis and subsequent histological and pathological analyses. Diagnosis Metastatic melanoma from an unknown primary tumor. Management The patient was treated with ipilimumab on a compassionate-use program and dexamethasone, celecoxib, and levetiracetam to treat the symptoms and seizures. Postoperative stereotactic radiosurgery was initiated.Keywords
This publication has 14 references indexed in Scilit:
- CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivoInternational Journal of Cancer, 2007
- CD4+CD25+FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomasJournal of Neuro-Oncology, 2007
- Blockade of CTLA-4 on CD4+CD25+ Regulatory T Cells Abrogates Their Function In VivoPublished by The American Association of Immunologists ,2006
- CNS immune privilege: hiding in plain sightImmunological Reviews, 2006
- Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain MetastasesJAMA, 2006
- Checkpoint Blockade in Cancer ImmunotherapyAdvances in Immunology, 2006
- The TLR-7 Agonist, Imiquimod, Enhances Dendritic Cell Survival and Promotes Tumor Antigen-Specific T Cell Priming: Relation to Central Nervous System Antitumor ImmunityPublished by The American Association of Immunologists ,2006
- Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor MicroenvironmentClinical Cancer Research, 2005
- The treatment of brain metastases in melanoma patientsCancer Treatment Reviews, 2004
- Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanomaJournal of Neurosurgery, 1998